9th Annual Biomarkers Congress

View Profile


Grant Support

Start year End year Title Source Position
1. 2007 2012 Adjuvants and Virosomal Vaccines for the Elderly National Institutes of Health Principal Investigator
2. 2008 2011 Correlates of Protection Against Influenza Illness: From Mouse Models to Older Adults Canadian Institutes of Health Research Principal Investigator
3. 2008 2011 Inflammaging, Diabetes & Metabolic Syndrome: Effect on T-cell Responses To Influenza Canadian Institutes of Health Research Principal Investigator
4. 2010 Identifying Immune Biomarkers that Predict Influenza in the Nursing Home Elderly Canadian Institutes of Health Research Co Investigator
5. 2005 2010 A Strategy to Optimize Vaccine Efficacy in Older Adults Donaghue Investigator Award Principal Investigator
6. 2005 2010 T-Cell Responses Predict Influenza Risk in Older Adults National Institutes of Health Principal Investigator
7. 2009 Cellular Immunity to Category A-C Viruses in Humans National Institutes of Health Co Investigator
8. 2008 2009 VITALiTY Team Planning Grant Michael Smith Foundation for Health Research Principal Investigator
9. 2007 2009 The Effect of Chronic Obstructive Pulmonary Disease on Age-Related Changes in the Immune Response to Influenza BC Lung Association Principal Investigator
10. 2007 2008 The Roadmap to Improved Correlates of Protection Against Influenza Canadian Institute of Health Research Principal Investigator
11. 2007 2008 T Cell Responses to Influenza Vaccination in Older Adults GlaxoSmithKline Principal Investigator
12. 2005 2006 V.I.P.: Vaccinate for Influenza Prevention Centers for Disease Control Principal Investigator
13. 2003 2006 Primary Care Research Infrastructure, Development and Education HRSA Academic Administrative Unit Award Co Investigator
14. 2002 2005 T-Cell Responses Predict Influenza Risk in Older Adults National Institutes of Health Principal Investigator
15. 2002 2005 Excellence in Primary Care Research Training HRSA Co Investigator
16. 2002 2004 Cytokines in Innate Immunity: Effect on CTL Centers for Disease Control Principal Investigator
17. 2003 A Randomized Double-Blind Placebo-Controlled Trial of a Respiratory Syncytial Virus Vaccine in High-Risk Older Adults” Phase IIB Clinical Trial Aventis Pasteur Inc Principal Investigator
18. 2003 Reducing Prostate Cancer Mortality in Hampton Roads Norfolk Foundation Principal Investigator
19. 2000 2001 A Double-Blind Placebo-Controlled, Randomized Study comparing the Effects of CVT-E002 (American Ginseng Extract) and Placebo in Naturally Occurring Respiratory Illness in Frail Older Adults CV Technologies-Edmonton Canada Principal Investigator
20. 2000 2001 Effect of Congestive Heart Failure on the Cellular Immune Response to Influenza Vaccination Commonwealth Health Research Board Principal Investigator
21. 1998 2001 Safety and Immunogenticity of Influenza Virus Vaccine USP Trivalent Types A and B (Zonal Purified Subvirion) Fluzone 1998/1999 Formula Pasteur Merieux Connaught Co Investigator
22. 2000 Safety and Immunogenticity of Influenza Virus Vaccine USP Trivalent Types A and B (Zonal Purified Subvirion) Fluzone 2000/2001 Formula Aventis Pasteur Inc. Principal Investigator
23. 2000 Effect of Re-Vaccination on the Humoral and Cellular Immune Response to Influenza Vaccination CV Technologies-Edmonton Canada Aventis Pasteur Inc. Principal Investigator
24. 2000 A Three Year Multicenter, Double-Blind, Parallel Comparison of Candersartan Cilexetil and Placebo on Elderly Mild Hypertensive Patients Columbia University Co Investigator
25. 1999 A Double-Blind, Randomized, Parallel-Group, Multi-Center Study to Investigate the Efficacy and Safety of inhaled Zanamivir 10 mg Once a Day Compared to Standard of Care in Controlling Nursing Home Influenza Outbreaks Glaxo Wellcome, Inc. Co Investigator
26. 1999 Safety and Immunogenticity of Influenza Virus Vaccine USP Trivalent Types A and B (Zonal Purified Subvirion) Fluzone 1999/2000 Formula Pasteur Merieux Connaught Principal Investigator
27. 1999 A Double-Blind Placebo-Controlled, Randomized Study comparing the Effects of CVT-E002 (American Ginseng Extract) and Placebo in Naturally Occurring Respiratory Illness in Frail Older Adults CV Technologies - Edmonton Canada Principal Investigator
28. 1999 Evaluation of the Antihypertensive Efficacy of Candersartan Cilexetil in Comparison to Losartan: A Multicenter, Double-Blind, Randomized, Parallel Group, Forced-Titration Study (CLAIM) AstraZeneca, LP Principal Investigator
29. 1999 Natural Course of Respiratory Syncytial Virus (RSV) Titers in Pediatrics and Adult Population During the 1999-2000 RSV Season Genetics Institute Co Investigator
30. 1994 1999 Age and Vaccine Modulation of Influenza National Institutes of Health Principal Investigator
31. 1998 Metifonate Investigational National Trail (M.I.N.T.) The Treatment of Alzheimer's Patients Bayer Corporation Co Investigator
32. 1998 SCOPE (Study on Cognition and Prognosis in Elderly). A prospective, randomized, double-blind, parallel comparison on candesartan cilexetil and placebo on elderly mild hypertensive patients Astra Merck Co Investigator
33. 1998 Nasopharyngeal Colonization of Adults by Resistant Organisms Glennan Center-Eastern Virginia Medical School Co Investigator
34. 1998 Upper Respiratory Infection Specimen Procurement/B Quidel Corporation Co Investigator
35. 1998 A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety in and Tolerability of Oral Once-Daily Prucalopride (R108512) Solution in Constipated Subjects Living in a Nursing Facility Janssen Research Foundation Co Investigator
36. 1998 A Multicenter, Double-Blind, Parallel Group Study Comparing the Incidence of Clinically Significant Upper Gastrointestinal Adverse Events Associated with SC-58635 400 mg BID to that of Diclofenac 75 mg BID in Patients w/ Osteoarthritis or Rheum. Arthritis Searle Research and Development Co Investigator
37. 1997 Pneumococcal Vaccination Program University of Alberta Hospitals Principal Investigator
38. 1997 Predictors of post-operation delirium in seniors undergoing coronary artery bypass surgery University of Alberta Hospitals Principal Investigator
39. 1994 1997 T-cell Responses to Influenza Vaccination in the Elderly - assays of T-cell Mediated Immune Responses to Vaccines Connaught Laboratories Principal Investigator
40. 1996 A Multidiscplinary Care Plan for Delirium Capital Health Authority Principal Investigator
41. 1996 Acute Risk Management for Seniors Clinic - Outcome Measures Health & Welfare Canada, New Horizons Project Principal Investigator
42. 1996 A Novel Method for Measuring Cytotoxic T-Lymphocyte Responses to Influenza Vaccination Alberta Heritage Foundation of Medical Research Principal Investigator
43. 1994 1996 T-cell Responses to Influenza Vaccination in the Elderly Medical Research Council of Canada Principal Investigator
44. 1995 Hospital-based Vaccination Program for the Elderly University of Alberta Hospitals Principal Investigator
45. 1995 Nutrition in the Elderly University of Alberta Hospitals Principal Investigator
46. 1995 Geriatric Assessment Team University of Alberta Hospitals Principal Investigator
47. 1994 1995 Nutrition in the Elderly - Benefits of Providing Nutritional Support Post-hospital Discharge Canadian Foundation for Dietetic Research Principal Investigator
48. 1994 T-cell Responses to Influenza Vaccination in the Elderly Merck Frosst Principal Investigator


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.